In a separate NSCLC data set, the majority of tumours with highFATE1 expression also exhibited elevated RNF183 expression, and again, highexpression of both genes predicted shortened overall survival time(HR=2.80; P<0.0001; Cox Regression) (Fig. 3l). This evidence concerns the gene RNF183 and neoplasm.